7th-8th February 2019

4th Annual Biomarker and Companion Diagnostics Conference

The Westin San Diego Gaslamp Quarter 910 Broadway Cir, San Diego, CA 92101, USA
26+
Speakers
20+
Sponsors
100
Attendees
10+
Networking Hours
3
Sessions

Biomarker is constantly evolving as the latent for the development of innovative drugs and diagnostic assays for early detection of disease. The major developments are witnessed in immune therapies where breakthroughs will be appearing soon.

The 4th Annual Biomarker and Companion Diagnostics Conference scheduled to be held on 7th-8th February 2019 in San Diego, CA would address the gaps between early stage biomarker development and the commercialization stage of biomarkers. Regarding commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in the companion diagnostics area. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers.

users

Learn from 20+ industry leading speakers who will be sharing their presentations and use cases on Non-invasive diagnosis of lung cancer, disruptive technologies in biomarker research, Next-generation CAR T-cells, Cloud software solutions for Clinical assays experiences.

users

Facilitated networking sessions to ensure quality interactions which include one on one query handling by biomarker experts and the opportunity to develop long-lasting business relationships and networking opportunities with senior peers.

users

Latest updates on regulatory guidelines and approvals, NGS and novel technologies in biomarker discovery, Commercialization of biomarkers in therapeutic and CDx applications with senior leaders from the Biomarker Industry.

We also have a UK Edition which will be held on 3 - 4 October 2019. View more details about the conference here.

We will soon be announcing the Dates and Venue for the 5th Biomarker and Companion Diagnostics Conference 2020. Email us on events@marketsandmakets.com to book your place at the conference.

WHAT TO EXPECT
Sessions
  • Clinical Biomarker Identification & Qualification
  • Biomarker and Personalized Medicine
  • Commercializing Biomarkers in Therapeutic and Companion Diagnostic Applications
Who Should Attend

Researchers, scientists, clinicians, academicians and professionals working in Biomarker discovery/development, Translational research, Clinical Biomarker, Biomarkers in IO and Neurological disorders, Imaging Biomarkers, Pathology, Companion Diagnostics

Key Highlights
  • Clinical biomarker identification and qualification
  • Biomarkers and personalized medicine
  • Assay development and validation
Companies Attending

Novartis | Pfizer | AbbVie | Janssen Research & Development, LLC | Thermofisher Scientific | Sanofi | Celgene | Cellectis | Takeda Pharmaceuticals

CONFERENCE SPEAKERS
Advisors
Steve Richards

Steve Richards

Investigator, Biomarker Expert
Novartis

Steve Richards

Investigator, Biomarker Expert
Novartis
Katherine Call

Katherine Call

Head, Proteogenomics
Genzyme Sanofi

Katherine Call

Head, Proteogenomics
Genzyme Sanofi
Speakers
Steve Richards

Steve Richards

Investigator, Biomarker Expert
Novartis

Steve Richards

Investigator, Biomarker Expert
Novartis
Katherine Call

Katherine Call

Head, Proteogenomics
Genzyme Sanofi

Katherine Call

Head, Proteogenomics
Genzyme Sanofi
Pallavi Sachdev

Pallavi Sachdev

Senior Director, Clinical Pharmacology and Translational Medicine
Eisai

Pallavi Sachdev

Senior Director, Clinical Pharmacology and Translational Medicine
Eisai
John Rossi

John Rossi

Director, Translational Sciences
Kite Pharma

John Rossi

Director, Translational Sciences
Kite Pharma
Howard Federoff

Howard Federoff

Professor of Neurology
University of California

Howard Federoff

Professor of Neurology
University of California
Iman Jilani

Iman Jilani

Director, Oncology Clinical Assay Group
Pfizer

Iman Jilani

Director, Oncology Clinical Assay Group
Pfizer
Mike Baratta

Mike Baratta

Scientific Director, Translational Biomarker Research
Takeda

Mike Baratta

Scientific Director, Translational Biomarker Research
Takeda
Jaya Goyal

Jaya Goyal

Vice President, Bioanalytical, Pharmacology and Biomarker Development
Wave Lifesciences

Jaya Goyal

Vice President, Bioanalytical, Pharmacology and Biomarker Development
Wave Lifesciences
Joshua LaBaer

Joshua LaBaer

Director, Executive Director and Professor
University of Arizona

Joshua LaBaer

Director, Executive Director and Professor
University of Arizona
Julianne Smith

Julianne Smith

Head, Translational Medicine
Cellectis

Julianne Smith

Head, Translational Medicine
Cellectis
Qihong Huang

Qihong Huang

Senior Principal Scientist
Boehringer Ingelheim

Qihong Huang

Senior Principal Scientist
Boehringer Ingelheim
Mark Ma

Mark Ma

Head, Bioanalytical and Biomarker Development
Alexion Pharmaceuticals

Mark Ma

Head, Bioanalytical and Biomarker Development
Alexion Pharmaceuticals
Paul Wood

Paul Wood

Director, Metabolomics Unit, Professor, Associate Dean of Research
Lincoln Memorial University

Paul Wood

Director, Metabolomics Unit, Professor, Associate Dean of Research
Lincoln Memorial University
James McDuffie

James McDuffie

Scientific Director
Janssen Research & Development

James McDuffie

Scientific Director
Janssen Research & Development
Adil Daud

Adil Daud

Clinical Professor
UCSF

Adil Daud

Clinical Professor
UCSF
Jeff Miller

Jeff Miller

CEO, CSO
Invivoscribe

Jeff Miller

CEO, CSO
Invivoscribe
Will Westra

Will Westra

Senior Director of Business Development
Oxford BioDynamics

Will Westra

Senior Director of Business Development
Oxford BioDynamics
Ken Bloom

Ken Bloom

Chief Medical Officer
Ambry Genetics

Ken Bloom

Chief Medical Officer
Ambry Genetics
Thomas Briggs

Thomas Briggs

Senior Key Account and Business Development Manager
Becton Dickinson

Thomas Briggs

Senior Key Account and Business Development Manager
Becton Dickinson
Rolf Muller

Rolf Muller

CEO
BioFluidica

Rolf Muller

CEO
BioFluidica
Zhen Mahoney

Zhen Mahoney

Head, Business Development
Asuragen

Zhen Mahoney

Head, Business Development
Asuragen
Catherine Sanders

Catherine Sanders

Senior Director, Research and Business Development
Adaptive Biotechnologies

Catherine Sanders

Senior Director, Research and Business Development
Adaptive Biotechnologies
John Todd

John Todd

Senior Vice President and Chief Scientific Officer
Singulex

John Todd

Senior Vice President and Chief Scientific Officer
Singulex
Timothy Tak-Chun

Timothy Tak-Chun

Senior Medical Science Director
ACT Genomics

Timothy Tak-Chun

Senior Medical Science Director
ACT Genomics
Bianca Heinrich

Bianca Heinrich

Senior Scientist
AbCam

Bianca Heinrich

Senior Scientist
AbCam
Sarah Wang

Sarah Wang

Director of Bioinformatics and Data Science
CareDx

Sarah Wang

Director of Bioinformatics and Data Science
CareDx
PARTNERS
Supporting Association
example-image

BioPartner UK

example-image

California Life Sciences Association (CLSA)

LOCATION
The Westin San Diego Gaslamp Quarter 910 Broadway Cir, San Diego, CA 92101, USA
About the Hotel

Optimally situated in the heart of downtown, The Westin San Diego Gaslamp Quarter is a revitalizing urban escape. Our AAA Four Diamond hotel features intuitively designed guestrooms and suites, replete with our award-winning Westin Heavenly Bed?, eco-friendly amenities and personalized touches. Make use of 35,000 square feet of indoor and outdoor event space. Throughout, you'll enjoy the thoughtful service and attention to detail that makes The Westin so distinctive.

For further information, please contact: Email: events@marketsandmarkets.com

PAST EVENT GALLERY